Global GABA Receptor Agonist Drug Supply, Demand and Key Producers, 2023-2029

Page: 124

Published Date: 07 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global GABA Receptor Agonist Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GABA Receptor Agonist Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GABA Receptor Agonist Drug that contribute to its increasing demand across many markets.

The global GABA Receptor Agonist Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global GABA Receptor Agonist Drug total production and demand, 2018-2029, (K Pcs)
Global GABA Receptor Agonist Drug total production value, 2018-2029, (USD Million)
Global GABA Receptor Agonist Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global GABA Receptor Agonist Drug consumption by region & country, CAGR, 2018-2029 & (K Pcs)
U.S. VS China: GABA Receptor Agonist Drug domestic production, consumption, key domestic manufacturers and share
Global GABA Receptor Agonist Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Pcs)
Global GABA Receptor Agonist Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global GABA Receptor Agonist Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
This reports profiles key players in the global GABA Receptor Agonist Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline and NovaDel Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GABA Receptor Agonist Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GABA Receptor Agonist Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global GABA Receptor Agonist Drug Market, Segmentation by Type
    Bamaluzole
    Phenibut
    Baclofen
    Gaboxadol
    Klonopin (clonazepam)
    Tiagbine

Global GABA Receptor Agonist Drug Market, Segmentation by Application
    Attention Deficit Hyperactivity Disorder (ADHD)
    Psychiatric Disorders and Depression
    Alzheimer
    Epilepsy and Seizure
    Anxiety and Sleep Disorders
    Obesity and Alcoholism

Companies Profiled:
    Advicenne
    AstraZeneca
    Athena Drug Delivery Solutions
    Biocodex
    Elan Corporation
    Eli Lilly and Company
    H.LundBeck, Merck and Co
    GlaxoSmithKline
    NovaDel Pharma
    Novartis
    OVATION Pharmaceuticals
    Osmotica Pharmaceutical
    Pfizer
    sanofi-aventis
    VIVUS
    XenoPort

Key Questions Answered
1. How big is the global GABA Receptor Agonist Drug market?
2. What is the demand of the global GABA Receptor Agonist Drug market?
3. What is the year over year growth of the global GABA Receptor Agonist Drug market?
4. What is the production and production value of the global GABA Receptor Agonist Drug market?
5. Who are the key producers in the global GABA Receptor Agonist Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 GABA Receptor Agonist Drug Introduction
    1.2 World GABA Receptor Agonist Drug Supply & Forecast
        1.2.1 World GABA Receptor Agonist Drug Production Value (2018 & 2022 & 2029)
        1.2.2 World GABA Receptor Agonist Drug Production (2018-2029)
        1.2.3 World GABA Receptor Agonist Drug Pricing Trends (2018-2029)
    1.3 World GABA Receptor Agonist Drug Production by Region (Based on Production Site)
        1.3.1 World GABA Receptor Agonist Drug Production Value by Region (2018-2029)
        1.3.2 World GABA Receptor Agonist Drug Production by Region (2018-2029)
        1.3.3 World GABA Receptor Agonist Drug Average Price by Region (2018-2029)
        1.3.4 North America GABA Receptor Agonist Drug Production (2018-2029)
        1.3.5 Europe GABA Receptor Agonist Drug Production (2018-2029)
        1.3.6 China GABA Receptor Agonist Drug Production (2018-2029)
        1.3.7 Japan GABA Receptor Agonist Drug Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 GABA Receptor Agonist Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 GABA Receptor Agonist Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World GABA Receptor Agonist Drug Demand (2018-2029)
    2.2 World GABA Receptor Agonist Drug Consumption by Region
        2.2.1 World GABA Receptor Agonist Drug Consumption by Region (2018-2023)
        2.2.2 World GABA Receptor Agonist Drug Consumption Forecast by Region (2024-2029)
    2.3 United States GABA Receptor Agonist Drug Consumption (2018-2029)
    2.4 China GABA Receptor Agonist Drug Consumption (2018-2029)
    2.5 Europe GABA Receptor Agonist Drug Consumption (2018-2029)
    2.6 Japan GABA Receptor Agonist Drug Consumption (2018-2029)
    2.7 South Korea GABA Receptor Agonist Drug Consumption (2018-2029)
    2.8 ASEAN GABA Receptor Agonist Drug Consumption (2018-2029)
    2.9 India GABA Receptor Agonist Drug Consumption (2018-2029)

3 World GABA Receptor Agonist Drug Manufacturers Competitive Analysis
    3.1 World GABA Receptor Agonist Drug Production Value by Manufacturer (2018-2023)
    3.2 World GABA Receptor Agonist Drug Production by Manufacturer (2018-2023)
    3.3 World GABA Receptor Agonist Drug Average Price by Manufacturer (2018-2023)
    3.4 GABA Receptor Agonist Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global GABA Receptor Agonist Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for GABA Receptor Agonist Drug in 2022
        3.5.3 Global Concentration Ratios (CR8) for GABA Receptor Agonist Drug in 2022
    3.6 GABA Receptor Agonist Drug Market: Overall Company Footprint Analysis
        3.6.1 GABA Receptor Agonist Drug Market: Region Footprint
        3.6.2 GABA Receptor Agonist Drug Market: Company Product Type Footprint
        3.6.3 GABA Receptor Agonist Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: GABA Receptor Agonist Drug Production Value Comparison
        4.1.1 United States VS China: GABA Receptor Agonist Drug Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: GABA Receptor Agonist Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: GABA Receptor Agonist Drug Production Comparison
        4.2.1 United States VS China: GABA Receptor Agonist Drug Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: GABA Receptor Agonist Drug Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: GABA Receptor Agonist Drug Consumption Comparison
        4.3.1 United States VS China: GABA Receptor Agonist Drug Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: GABA Receptor Agonist Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based GABA Receptor Agonist Drug Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers GABA Receptor Agonist Drug Production Value (2018-2023)
        4.4.3 United States Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023)
    4.5 China Based GABA Receptor Agonist Drug Manufacturers and Market Share
        4.5.1 China Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers GABA Receptor Agonist Drug Production Value (2018-2023)
        4.5.3 China Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023)
    4.6 Rest of World Based GABA Receptor Agonist Drug Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers GABA Receptor Agonist Drug Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023)

5 Market Analysis by Type
    5.1 World GABA Receptor Agonist Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Bamaluzole
        5.2.2 Phenibut
        5.2.3 Baclofen
        5.2.4 Gaboxadol
        5.2.5 Klonopin (clonazepam)
        5.2.6 Tiagbine
    5.3 Market Segment by Type
        5.3.1 World GABA Receptor Agonist Drug Production by Type (2018-2029)
        5.3.2 World GABA Receptor Agonist Drug Production Value by Type (2018-2029)
        5.3.3 World GABA Receptor Agonist Drug Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World GABA Receptor Agonist Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Attention Deficit Hyperactivity Disorder (ADHD)
        6.2.2 Psychiatric Disorders and Depression
        6.2.3 Alzheimer
        6.2.4 Epilepsy and Seizure
        6.2.5 Anxiety and Sleep Disorders
        6.2.6 Obesity and Alcoholism
    6.3 Market Segment by Application
        6.3.1 World GABA Receptor Agonist Drug Production by Application (2018-2029)
        6.3.2 World GABA Receptor Agonist Drug Production Value by Application (2018-2029)
        6.3.3 World GABA Receptor Agonist Drug Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Advicenne
        7.1.1 Advicenne Details
        7.1.2 Advicenne Major Business
        7.1.3 Advicenne GABA Receptor Agonist Drug Product and Services
        7.1.4 Advicenne GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Advicenne Recent Developments/Updates
        7.1.6 Advicenne Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca GABA Receptor Agonist Drug Product and Services
        7.2.4 AstraZeneca GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Athena Drug Delivery Solutions
        7.3.1 Athena Drug Delivery Solutions Details
        7.3.2 Athena Drug Delivery Solutions Major Business
        7.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
        7.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Athena Drug Delivery Solutions Recent Developments/Updates
        7.3.6 Athena Drug Delivery Solutions Competitive Strengths & Weaknesses
    7.4 Biocodex
        7.4.1 Biocodex Details
        7.4.2 Biocodex Major Business
        7.4.3 Biocodex GABA Receptor Agonist Drug Product and Services
        7.4.4 Biocodex GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Biocodex Recent Developments/Updates
        7.4.6 Biocodex Competitive Strengths & Weaknesses
    7.5 Elan Corporation
        7.5.1 Elan Corporation Details
        7.5.2 Elan Corporation Major Business
        7.5.3 Elan Corporation GABA Receptor Agonist Drug Product and Services
        7.5.4 Elan Corporation GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Elan Corporation Recent Developments/Updates
        7.5.6 Elan Corporation Competitive Strengths & Weaknesses
    7.6 Eli Lilly and Company
        7.6.1 Eli Lilly and Company Details
        7.6.2 Eli Lilly and Company Major Business
        7.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
        7.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Eli Lilly and Company Recent Developments/Updates
        7.6.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.7 H.LundBeck, Merck and Co
        7.7.1 H.LundBeck, Merck and Co Details
        7.7.2 H.LundBeck, Merck and Co Major Business
        7.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
        7.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 H.LundBeck, Merck and Co Recent Developments/Updates
        7.7.6 H.LundBeck, Merck and Co Competitive Strengths & Weaknesses
    7.8 GlaxoSmithKline
        7.8.1 GlaxoSmithKline Details
        7.8.2 GlaxoSmithKline Major Business
        7.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
        7.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 GlaxoSmithKline Recent Developments/Updates
        7.8.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.9 NovaDel Pharma
        7.9.1 NovaDel Pharma Details
        7.9.2 NovaDel Pharma Major Business
        7.9.3 NovaDel Pharma GABA Receptor Agonist Drug Product and Services
        7.9.4 NovaDel Pharma GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 NovaDel Pharma Recent Developments/Updates
        7.9.6 NovaDel Pharma Competitive Strengths & Weaknesses
    7.10 Novartis
        7.10.1 Novartis Details
        7.10.2 Novartis Major Business
        7.10.3 Novartis GABA Receptor Agonist Drug Product and Services
        7.10.4 Novartis GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis Recent Developments/Updates
        7.10.6 Novartis Competitive Strengths & Weaknesses
    7.11 OVATION Pharmaceuticals
        7.11.1 OVATION Pharmaceuticals Details
        7.11.2 OVATION Pharmaceuticals Major Business
        7.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
        7.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 OVATION Pharmaceuticals Recent Developments/Updates
        7.11.6 OVATION Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Osmotica Pharmaceutical
        7.12.1 Osmotica Pharmaceutical Details
        7.12.2 Osmotica Pharmaceutical Major Business
        7.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
        7.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Osmotica Pharmaceutical Recent Developments/Updates
        7.12.6 Osmotica Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Pfizer
        7.13.1 Pfizer Details
        7.13.2 Pfizer Major Business
        7.13.3 Pfizer GABA Receptor Agonist Drug Product and Services
        7.13.4 Pfizer GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Pfizer Recent Developments/Updates
        7.13.6 Pfizer Competitive Strengths & Weaknesses
    7.14 sanofi-aventis
        7.14.1 sanofi-aventis Details
        7.14.2 sanofi-aventis Major Business
        7.14.3 sanofi-aventis GABA Receptor Agonist Drug Product and Services
        7.14.4 sanofi-aventis GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 sanofi-aventis Recent Developments/Updates
        7.14.6 sanofi-aventis Competitive Strengths & Weaknesses
    7.15 VIVUS
        7.15.1 VIVUS Details
        7.15.2 VIVUS Major Business
        7.15.3 VIVUS GABA Receptor Agonist Drug Product and Services
        7.15.4 VIVUS GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 VIVUS Recent Developments/Updates
        7.15.6 VIVUS Competitive Strengths & Weaknesses
    7.16 XenoPort
        7.16.1 XenoPort Details
        7.16.2 XenoPort Major Business
        7.16.3 XenoPort GABA Receptor Agonist Drug Product and Services
        7.16.4 XenoPort GABA Receptor Agonist Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 XenoPort Recent Developments/Updates
        7.16.6 XenoPort Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 GABA Receptor Agonist Drug Industry Chain
    8.2 GABA Receptor Agonist Drug Upstream Analysis
        8.2.1 GABA Receptor Agonist Drug Core Raw Materials
        8.2.2 Main Manufacturers of GABA Receptor Agonist Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 GABA Receptor Agonist Drug Production Mode
    8.6 GABA Receptor Agonist Drug Procurement Model
    8.7 GABA Receptor Agonist Drug Industry Sales Model and Sales Channels
        8.7.1 GABA Receptor Agonist Drug Sales Model
        8.7.2 GABA Receptor Agonist Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World GABA Receptor Agonist Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World GABA Receptor Agonist Drug Production Value by Region (2018-2023) & (USD Million)
    Table 3. World GABA Receptor Agonist Drug Production Value by Region (2024-2029) & (USD Million)
    Table 4. World GABA Receptor Agonist Drug Production Value Market Share by Region (2018-2023)
    Table 5. World GABA Receptor Agonist Drug Production Value Market Share by Region (2024-2029)
    Table 6. World GABA Receptor Agonist Drug Production by Region (2018-2023) & (K Pcs)
    Table 7. World GABA Receptor Agonist Drug Production by Region (2024-2029) & (K Pcs)
    Table 8. World GABA Receptor Agonist Drug Production Market Share by Region (2018-2023)
    Table 9. World GABA Receptor Agonist Drug Production Market Share by Region (2024-2029)
    Table 10. World GABA Receptor Agonist Drug Average Price by Region (2018-2023) & (USD/Pcs)
    Table 11. World GABA Receptor Agonist Drug Average Price by Region (2024-2029) & (USD/Pcs)
    Table 12. GABA Receptor Agonist Drug Major Market Trends
    Table 13. World GABA Receptor Agonist Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Pcs)
    Table 14. World GABA Receptor Agonist Drug Consumption by Region (2018-2023) & (K Pcs)
    Table 15. World GABA Receptor Agonist Drug Consumption Forecast by Region (2024-2029) & (K Pcs)
    Table 16. World GABA Receptor Agonist Drug Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key GABA Receptor Agonist Drug Producers in 2022
    Table 18. World GABA Receptor Agonist Drug Production by Manufacturer (2018-2023) & (K Pcs)
    Table 19. Production Market Share of Key GABA Receptor Agonist Drug Producers in 2022
    Table 20. World GABA Receptor Agonist Drug Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 21. Global GABA Receptor Agonist Drug Company Evaluation Quadrant
    Table 22. World GABA Receptor Agonist Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and GABA Receptor Agonist Drug Production Site of Key Manufacturer
    Table 24. GABA Receptor Agonist Drug Market: Company Product Type Footprint
    Table 25. GABA Receptor Agonist Drug Market: Company Product Application Footprint
    Table 26. GABA Receptor Agonist Drug Competitive Factors
    Table 27. GABA Receptor Agonist Drug New Entrant and Capacity Expansion Plans
    Table 28. GABA Receptor Agonist Drug Mergers & Acquisitions Activity
    Table 29. United States VS China GABA Receptor Agonist Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China GABA Receptor Agonist Drug Production Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 31. United States VS China GABA Receptor Agonist Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 32. United States Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers GABA Receptor Agonist Drug Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers GABA Receptor Agonist Drug Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023) & (K Pcs)
    Table 36. United States Based Manufacturers GABA Receptor Agonist Drug Production Market Share (2018-2023)
    Table 37. China Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers GABA Receptor Agonist Drug Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers GABA Receptor Agonist Drug Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023) & (K Pcs)
    Table 41. China Based Manufacturers GABA Receptor Agonist Drug Production Market Share (2018-2023)
    Table 42. Rest of World Based GABA Receptor Agonist Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers GABA Receptor Agonist Drug Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers GABA Receptor Agonist Drug Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers GABA Receptor Agonist Drug Production (2018-2023) & (K Pcs)
    Table 46. Rest of World Based Manufacturers GABA Receptor Agonist Drug Production Market Share (2018-2023)
    Table 47. World GABA Receptor Agonist Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World GABA Receptor Agonist Drug Production by Type (2018-2023) & (K Pcs)
    Table 49. World GABA Receptor Agonist Drug Production by Type (2024-2029) & (K Pcs)
    Table 50. World GABA Receptor Agonist Drug Production Value by Type (2018-2023) & (USD Million)
    Table 51. World GABA Receptor Agonist Drug Production Value by Type (2024-2029) & (USD Million)
    Table 52. World GABA Receptor Agonist Drug Average Price by Type (2018-2023) & (USD/Pcs)
    Table 53. World GABA Receptor Agonist Drug Average Price by Type (2024-2029) & (USD/Pcs)
    Table 54. World GABA Receptor Agonist Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World GABA Receptor Agonist Drug Production by Application (2018-2023) & (K Pcs)
    Table 56. World GABA Receptor Agonist Drug Production by Application (2024-2029) & (K Pcs)
    Table 57. World GABA Receptor Agonist Drug Production Value by Application (2018-2023) & (USD Million)
    Table 58. World GABA Receptor Agonist Drug Production Value by Application (2024-2029) & (USD Million)
    Table 59. World GABA Receptor Agonist Drug Average Price by Application (2018-2023) & (USD/Pcs)
    Table 60. World GABA Receptor Agonist Drug Average Price by Application (2024-2029) & (USD/Pcs)
    Table 61. Advicenne Basic Information, Manufacturing Base and Competitors
    Table 62. Advicenne Major Business
    Table 63. Advicenne GABA Receptor Agonist Drug Product and Services
    Table 64. Advicenne GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Advicenne Recent Developments/Updates
    Table 66. Advicenne Competitive Strengths & Weaknesses
    Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 68. AstraZeneca Major Business
    Table 69. AstraZeneca GABA Receptor Agonist Drug Product and Services
    Table 70. AstraZeneca GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. AstraZeneca Recent Developments/Updates
    Table 72. AstraZeneca Competitive Strengths & Weaknesses
    Table 73. Athena Drug Delivery Solutions Basic Information, Manufacturing Base and Competitors
    Table 74. Athena Drug Delivery Solutions Major Business
    Table 75. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
    Table 76. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Athena Drug Delivery Solutions Recent Developments/Updates
    Table 78. Athena Drug Delivery Solutions Competitive Strengths & Weaknesses
    Table 79. Biocodex Basic Information, Manufacturing Base and Competitors
    Table 80. Biocodex Major Business
    Table 81. Biocodex GABA Receptor Agonist Drug Product and Services
    Table 82. Biocodex GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Biocodex Recent Developments/Updates
    Table 84. Biocodex Competitive Strengths & Weaknesses
    Table 85. Elan Corporation Basic Information, Manufacturing Base and Competitors
    Table 86. Elan Corporation Major Business
    Table 87. Elan Corporation GABA Receptor Agonist Drug Product and Services
    Table 88. Elan Corporation GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Elan Corporation Recent Developments/Updates
    Table 90. Elan Corporation Competitive Strengths & Weaknesses
    Table 91. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 92. Eli Lilly and Company Major Business
    Table 93. Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
    Table 94. Eli Lilly and Company GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Eli Lilly and Company Recent Developments/Updates
    Table 96. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 97. H.LundBeck, Merck and Co Basic Information, Manufacturing Base and Competitors
    Table 98. H.LundBeck, Merck and Co Major Business
    Table 99. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
    Table 100. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. H.LundBeck, Merck and Co Recent Developments/Updates
    Table 102. H.LundBeck, Merck and Co Competitive Strengths & Weaknesses
    Table 103. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 104. GlaxoSmithKline Major Business
    Table 105. GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
    Table 106. GlaxoSmithKline GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. GlaxoSmithKline Recent Developments/Updates
    Table 108. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 109. NovaDel Pharma Basic Information, Manufacturing Base and Competitors
    Table 110. NovaDel Pharma Major Business
    Table 111. NovaDel Pharma GABA Receptor Agonist Drug Product and Services
    Table 112. NovaDel Pharma GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. NovaDel Pharma Recent Developments/Updates
    Table 114. NovaDel Pharma Competitive Strengths & Weaknesses
    Table 115. Novartis Basic Information, Manufacturing Base and Competitors
    Table 116. Novartis Major Business
    Table 117. Novartis GABA Receptor Agonist Drug Product and Services
    Table 118. Novartis GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Novartis Recent Developments/Updates
    Table 120. Novartis Competitive Strengths & Weaknesses
    Table 121. OVATION Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 122. OVATION Pharmaceuticals Major Business
    Table 123. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
    Table 124. OVATION Pharmaceuticals GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. OVATION Pharmaceuticals Recent Developments/Updates
    Table 126. OVATION Pharmaceuticals Competitive Strengths & Weaknesses
    Table 127. Osmotica Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 128. Osmotica Pharmaceutical Major Business
    Table 129. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
    Table 130. Osmotica Pharmaceutical GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Osmotica Pharmaceutical Recent Developments/Updates
    Table 132. Osmotica Pharmaceutical Competitive Strengths & Weaknesses
    Table 133. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 134. Pfizer Major Business
    Table 135. Pfizer GABA Receptor Agonist Drug Product and Services
    Table 136. Pfizer GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Pfizer Recent Developments/Updates
    Table 138. Pfizer Competitive Strengths & Weaknesses
    Table 139. sanofi-aventis Basic Information, Manufacturing Base and Competitors
    Table 140. sanofi-aventis Major Business
    Table 141. sanofi-aventis GABA Receptor Agonist Drug Product and Services
    Table 142. sanofi-aventis GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. sanofi-aventis Recent Developments/Updates
    Table 144. sanofi-aventis Competitive Strengths & Weaknesses
    Table 145. VIVUS Basic Information, Manufacturing Base and Competitors
    Table 146. VIVUS Major Business
    Table 147. VIVUS GABA Receptor Agonist Drug Product and Services
    Table 148. VIVUS GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. VIVUS Recent Developments/Updates
    Table 150. XenoPort Basic Information, Manufacturing Base and Competitors
    Table 151. XenoPort Major Business
    Table 152. XenoPort GABA Receptor Agonist Drug Product and Services
    Table 153. XenoPort GABA Receptor Agonist Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 154. Global Key Players of GABA Receptor Agonist Drug Upstream (Raw Materials)
    Table 155. GABA Receptor Agonist Drug Typical Customers
    Table 156. GABA Receptor Agonist Drug Typical Distributors
List of Figure
    Figure 1. GABA Receptor Agonist Drug Picture
    Figure 2. World GABA Receptor Agonist Drug Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World GABA Receptor Agonist Drug Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World GABA Receptor Agonist Drug Production (2018-2029) & (K Pcs)
    Figure 5. World GABA Receptor Agonist Drug Average Price (2018-2029) & (USD/Pcs)
    Figure 6. World GABA Receptor Agonist Drug Production Value Market Share by Region (2018-2029)
    Figure 7. World GABA Receptor Agonist Drug Production Market Share by Region (2018-2029)
    Figure 8. North America GABA Receptor Agonist Drug Production (2018-2029) & (K Pcs)
    Figure 9. Europe GABA Receptor Agonist Drug Production (2018-2029) & (K Pcs)
    Figure 10. China GABA Receptor Agonist Drug Production (2018-2029) & (K Pcs)
    Figure 11. Japan GABA Receptor Agonist Drug Production (2018-2029) & (K Pcs)
    Figure 12. GABA Receptor Agonist Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 15. World GABA Receptor Agonist Drug Consumption Market Share by Region (2018-2029)
    Figure 16. United States GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 17. China GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 18. Europe GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 19. Japan GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 20. South Korea GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 21. ASEAN GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 22. India GABA Receptor Agonist Drug Consumption (2018-2029) & (K Pcs)
    Figure 23. Producer Shipments of GABA Receptor Agonist Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for GABA Receptor Agonist Drug Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for GABA Receptor Agonist Drug Markets in 2022
    Figure 26. United States VS China: GABA Receptor Agonist Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: GABA Receptor Agonist Drug Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: GABA Receptor Agonist Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers GABA Receptor Agonist Drug Production Market Share 2022
    Figure 30. China Based Manufacturers GABA Receptor Agonist Drug Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers GABA Receptor Agonist Drug Production Market Share 2022
    Figure 32. World GABA Receptor Agonist Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World GABA Receptor Agonist Drug Production Value Market Share by Type in 2022
    Figure 34. Bamaluzole
    Figure 35. Phenibut
    Figure 36. Baclofen
    Figure 37. Gaboxadol
    Figure 38. Klonopin (clonazepam)
    Figure 39. Tiagbine
    Figure 40. World GABA Receptor Agonist Drug Production Market Share by Type (2018-2029)
    Figure 41. World GABA Receptor Agonist Drug Production Value Market Share by Type (2018-2029)
    Figure 42. World GABA Receptor Agonist Drug Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 43. World GABA Receptor Agonist Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 44. World GABA Receptor Agonist Drug Production Value Market Share by Application in 2022
    Figure 45. Attention Deficit Hyperactivity Disorder (ADHD)
    Figure 46. Psychiatric Disorders and Depression
    Figure 47. Alzheimer
    Figure 48. Epilepsy and Seizure
    Figure 49. Anxiety and Sleep Disorders
    Figure 50. Obesity and Alcoholism
    Figure 51. World GABA Receptor Agonist Drug Production Market Share by Application (2018-2029)
    Figure 52. World GABA Receptor Agonist Drug Production Value Market Share by Application (2018-2029)
    Figure 53. World GABA Receptor Agonist Drug Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 54. GABA Receptor Agonist Drug Industry Chain
    Figure 55. GABA Receptor Agonist Drug Procurement Model
    Figure 56. GABA Receptor Agonist Drug Sales Model
    Figure 57. GABA Receptor Agonist Drug Sales Channels, Direct Sales, and Distribution
    Figure 58. Methodology
    Figure 59. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global GABA Receptor Agonist Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global GABA Receptor Agonist Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 11 Feb 2021

date Pharma & Healthcare

The GABA Receptor Agonist Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global GABA Receptor Agonist Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global GABA Receptor Agonist Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Global GABA Receptor Agonist Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global GABA Receptor Agonist Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 16 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global GABA Receptor Agonist Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global GABA Receptor Agonist Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global GABA Receptor Agonist Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global GABA Receptor Agonist Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

gaba receptor agonist drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>